Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2008
DOI: 10.1007/s00894-008-0335-7
|View full text |Cite
|
Sign up to set email alerts
|

Data mining using template-based molecular docking on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1RT inhibitors

Abstract: TIBO (Tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone) compounds are potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) that show a great promise for the treatment of AIDS. A structure-based molecular modeling approach based on template-based flexible docking simulation followed by 'Tabu clustering' was performed on a series of 46 TIBO derivatives considered as training set of HIV-1 NNRTIs. Four different templates of the highest active ligand (pIC(50) = 8.52) of the series were used. The resul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 45 publications
0
3
0
Order By: Relevance
“…Computer-aided drug design (CADD) approaches have been widely used to discover, develop, and analyze drugs and similar potential bioactive molecules, reducing time and cost. , These approaches are divided into ligand-based and structure-based drug designs. The concept of structure-based drug design (SBDD) furnishes a deeper perceptive of the structure of the protein binding sites and various interlinkages coupled with them. The principle of docking is based on an energy-based scoring relation that distinguishes the most fitted conformation of ligand when accommodated to the receptor binding pocket. The extensive approach is based on the fact that lower energy scores suggest for more suitable binding of receptors and ligands in comparison to greater values of energy scores. In this way, the molecular docking aims at achieving a suitable ligand binding mode with the smallest energy .…”
Section: Introductionmentioning
confidence: 99%
“…Computer-aided drug design (CADD) approaches have been widely used to discover, develop, and analyze drugs and similar potential bioactive molecules, reducing time and cost. , These approaches are divided into ligand-based and structure-based drug designs. The concept of structure-based drug design (SBDD) furnishes a deeper perceptive of the structure of the protein binding sites and various interlinkages coupled with them. The principle of docking is based on an energy-based scoring relation that distinguishes the most fitted conformation of ligand when accommodated to the receptor binding pocket. The extensive approach is based on the fact that lower energy scores suggest for more suitable binding of receptors and ligands in comparison to greater values of energy scores. In this way, the molecular docking aims at achieving a suitable ligand binding mode with the smallest energy .…”
Section: Introductionmentioning
confidence: 99%
“…After steps of prefilters, a docking screening on the PubChem database finally yielded 20 compounds that might have enhanced binding affinities. In a later study, Sapre et al [55] improved the docking protocol by using incorporated templates, an enhanced pose clustering technique and a simplex evolution algorithm (MolDock SE) along with MolDock Grid. The more efficient docking protocol retrieved 25 novel TIBO-like compounds and six novel scaffolds from the PubChem database.…”
Section: Reverse Transcription Inhibitorsmentioning
confidence: 99%
“…25 Our earlier QSPR studies dealt with the lipophilicity of the AASBN series and the factors affecting it, 26 while the QSAR study was based on the utility of Kier-Hall electrotopological indices in depicting the substitution effects. 27 Computational methods have been instrumental in structure elucidation and drug development. These methods enhance the speed of the drug discovery process towards compounds with the desired activity profile.…”
Section: Introductionmentioning
confidence: 99%